Development and validation of risk stratification and shared decision-making tool for catheter ablation for atrial fibrillation in patients with heart failure: a multicentre cohort study
The National Key Research and Development Program of China, Beijing Hospitals Authority Yangfan Program, Engineering Research Center of Cardiovascular Diagnostic and Therapeutic Technologies and Devices, Ministry of Education and the National Natural Science Foundation of China.
Authors
- Jinzhu Hu (ORCID: https://orcid.org/0000-0002-1158-1061)
- Zixu Zhao (ORCID: https://orcid.org/0000-0002-1311-4299)
- Deyong Long
- Kui Hong
- Caihua Sang
- Zhuheng Li
- Jianzeng Dong (ORCID: https://orcid.org/0000-0002-2105-3852)
- Shijun Xia (ORCID: https://orcid.org/0000-0002-8099-8813)
- Nan Li (ORCID: https://orcid.org/0000-0002-9255-4638)
- Peng Zhang (ORCID: https://orcid.org/0000-0001-9705-8644)
- Xiaodong Peng
- Jing Cui (ORCID: https://orcid.org/0000-0002-9274-4511)
- Ning Zhou (ORCID: https://orcid.org/0009-0004-1993-1961)
- Xin Du (ORCID: https://orcid.org/0000-0001-7424-1438)
- Changsheng Ma
- Liu He (ORCID: https://orcid.org/0009-0007-2418-2389)
- Chao Jiang (ORCID: https://orcid.org/0009-0003-8617-422X)
- Jue Wang (ORCID: https://orcid.org/0009-0006-2492-3311)
Institutions
- Nanchang University (CN)
- Capital Medical University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Beijing Anzhen Hospital (CN)
- China National Health Development Research Center (CN)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-04-28
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103219
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00